Autor: "Starke CE" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.
Autorzy :: Rutishauser RL; Department of Medicine, UCSF, San Francisco, California, USA.
Deguit CDT; Department of Medicine, UCSF, San Francisco, California, USA.; Institute of Human Genetics, University of the Philippines-National Institutes of Health, Manila, Philippines.
Hiatt J; Department of Microbiology and Immunology.; Medical Scientist Training Program.; Biomedical Sciences Graduate Program, and.
Blaeschke F; Department of Microbiology and Immunology.; Diabetes Center, UCSF, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, Berkeley, California, USA.
Roth TL; Department of Microbiology and Immunology.; Medical Scientist Training Program.; Biomedical Sciences Graduate Program, and.
Wang L; Department of Medicine, UCSF, San Francisco, California, USA.
Raymond KA; Vitalant Research Institute, San Francisco, California, USA.; Department of Laboratory Medicine, UCSF, California, USA.
Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases and.
Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases and.
Chen W; Department of Medicine, UCSF, San Francisco, California, USA.
Smullin C; Department of Medicine, UCSF, San Francisco, California, USA.
Matus-Nicodemos R; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Hoh R; Department of Medicine, UCSF, San Francisco, California, USA.
Krone M; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
Hecht FM; Department of Medicine, UCSF, San Francisco, California, USA.
Pilcher CD; Department of Medicine, UCSF, San Francisco, California, USA.
Martin JN; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
Koup RA; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , NIH, Bethesda, Maryland, USA.
Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases and.
Sékaly RP; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Pillai SK; Vitalant Research Institute, San Francisco, California, USA.; Department of Laboratory Medicine, UCSF, California, USA.
Marson A; Department of Medicine, UCSF, San Francisco, California, USA.; Department of Microbiology and Immunology.; Diabetes Center, UCSF, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, Berkeley, California, USA.; Chan Zuckerberg Biohub, San Francisco, California, USA.; UCSF Hellen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Deeks SG; Department of Medicine, UCSF, San Francisco, California, USA.
McCune JM; Department of Medicine, UCSF, San Francisco, California, USA.
Hunt PW; Department of Medicine, UCSF, San Francisco, California, USA.; Pokaż więcej
Źródło :: JCI insight [JCI Insight] 2021 Feb 08; Vol. 6 (3). Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
Autorzy :: Hoang TN; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Pino M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Boddapati AK; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Viox EG; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Starke CE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Upadhyay AA; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Gumber S; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA; Division of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Strongin Z; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Harper JL; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Tharp GK; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Pellegrini KL; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Kirejczyk S; Division of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Zandi K; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Tao S; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Horton TR; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Beagle EN; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Mahar EA; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Lee MYH; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Cohen J; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Jean SM; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Wood JS; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Connor-Stroud F; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Stammen RL; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Delmas OM; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Wang S; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Cooney KA; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Sayegh MN; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Wang L; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Filev PD; Department of Radiology and Imaging Sciences, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Silvestri G; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Waggoner J; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Piantadosi A; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Kasturi SP; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Al-Shakhshir H; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Ribeiro SP; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Levit RD; Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Vanderford TH; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Schinazi RF; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA. Electronic address: .
Bosinger SE; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA. Electronic address: .
Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA. Electronic address: .; Pokaż więcej
Źródło :: Cell [Cell] 2021 Jan 21; Vol. 184 (2), pp. 460-475.e21. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Macaca mulatta*
Anti-Inflammatory Agents/*administration & dosage
Azetidines/*administration & dosage
COVID-19/*drug therapy
COVID-19/*immunology
Neutrophil Infiltration/*drug effects
Purines/*administration & dosage
Pyrazoles/*administration & dosage
Sulfonamides/*administration & dosage
Animals ; COVID-19/physiopathology ; Cell Death/drug effects ; Cell Degranulation/drug effects ; Disease Models, Animal ; Inflammation/drug therapy ; Inflammation/genetics ; Inflammation/immunology ; Janus Kinases/antagonists & inhibitors ; Lung/drug effects ; Lung/immunology ; Lung/pathology ; Lymphocyte Activation/drug effects ; Macrophages, Alveolar/immunology ; SARS-CoV-2/physiology ; Severity of Illness Index ; T-Lymphocytes/immunology ; Virus Replication/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
Autorzy :: Tostanoski LH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Wegmann F; Janssen Vaccines & Prevention BV, Leiden, Netherlands.
Martinot AJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.
Loos C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, MA, USA.
McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Mercado NB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Chan CN; Oregon Health & Sciences University, Beaverton, OR, USA.
Bondoc S; Oregon Health & Sciences University, Beaverton, OR, USA.
Starke CE; Oregon Health & Sciences University, Beaverton, OR, USA.
Nekorchuk M; Oregon Health & Sciences University, Beaverton, OR, USA.
Busman-Sahay K; Oregon Health & Sciences University, Beaverton, OR, USA.
Piedra-Mora C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.
Wrijil LM; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.
Ducat S; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.
Custers J; Janssen Vaccines & Prevention BV, Leiden, Netherlands.
Atyeo C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Burke JS; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Caradonna TM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Bondzie EA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Dagotto G; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Gebre MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Lin Z; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Mahrokhian SH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Nampanya F; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Nityanandam R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Pessaint L; Bioqual, Rockville, MD, USA.
Porto M; Bioqual, Rockville, MD, USA.
Ali V; Bioqual, Rockville, MD, USA.
Benetiene D; Bioqual, Rockville, MD, USA.
Tevi K; Bioqual, Rockville, MD, USA.
Andersen H; Bioqual, Rockville, MD, USA.
Lewis MG; Bioqual, Rockville, MD, USA.
Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.
Lauffenburger DA; Massachusetts Institute of Technology, Cambridge, MA, USA.
Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.
Estes JD; Oregon Health & Sciences University, Beaverton, OR, USA.
Schuitemaker H; Janssen Vaccines & Prevention BV, Leiden, Netherlands.
Zahn R; Janssen Vaccines & Prevention BV, Leiden, Netherlands.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. .; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. .; Harvard Medical School, Boston, MA, USA. .; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA. .; Pokaż więcej
Źródło :: Nature medicine [Nat Med] 2020 Nov; Vol. 26 (11), pp. 1694-1700. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :: Adenoviridae/*genetics
COVID-19/*prevention & control
COVID-19 Vaccines/*therapeutic use
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*genetics
Spike Glycoprotein, Coronavirus/*immunology
Adenoviridae/immunology ; Animals ; Antibodies, Neutralizing/genetics ; Antibodies, Neutralizing/therapeutic use ; COVID-19/mortality ; COVID-19/pathology ; COVID-19/virology ; COVID-19 Vaccines/genetics ; Cricetinae ; Disease Models, Animal ; Female ; Genetic Vectors ; Humans ; Male ; Mesocricetus ; SARS-CoV-2/genetics ; Severity of Illness Index ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/therapeutic use ; Viral Load
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys.
Autorzy :: Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Lai S; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Shah S; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Rahmberg A; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Perkins MR; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.
Ransier A; Human Immunology Section, Vaccine Research Center, and.
Darko S; Human Immunology Section, Vaccine Research Center, and.
Douek DC; Human Immunology Section, Vaccine Research Center, and.
Hirsch VM; Nonhuman Primate Virology Section, Laboratory of Molecular Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Cameron M; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research.; Pokaż więcej
Źródło :: JCI insight [JCI Insight] 2020 Sep 17; Vol. 5 (18). Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients.
Autorzy :: Brook OR; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA. .
Piper KG; Department of Vascular Surgery, Beth Israel Deaconess Medical Center, Boston, USA.
Mercado NB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Gebre MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Busman-Sahay K; Vaccine & Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, OR, 97006, USA.
Starke CE; Vaccine & Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, OR, 97006, USA.
Estes JD; Vaccine & Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, OR, 97006, USA.
Martinot AJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Departments of Infectious Diseases and Global Health and Biomedical Sciences, Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA.
Wrijil L; Departments of Infectious Diseases and Global Health and Biomedical Sciences, Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA.
Ducat S; Departments of Infectious Diseases and Global Health and Biomedical Sciences, Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA.
Hecht JL; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Pokaż więcej
Źródło :: Abdominal radiology (New York) [Abdom Radiol (NY)] 2020 Sep 17. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
Autorzy :: Hoang TN; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Pino M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Boddapati AK; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Viox EG; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Starke CE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Upadhyay AA; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Gumber S; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.; Division of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Strongin Z; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Harper JL; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Tharp GK; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Pellegrini KL; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Kirejczyk S; Division of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Zandi K; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Tao S; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Horton TR; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Beagle EN; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Mahar EA; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Lee MY; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Cohen J; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Jean SM; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Wood JS; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Connor-Stroud F; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Stammen RL; Division of Animal Resources, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Delmas OM; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Wang S; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Cooney KA; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Sayegh MN; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Wang L; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Filev PD; Department of Radiology and Imaging Sciences, School of Medicine, Emory University, Atlanta, Georgia, USA.
Waggoner J; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Piantadosi A; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Kasturi SP; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Al-Shakhshir H; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Ribeiro SP; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Levit RD; Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Vanderford TH; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Schinazi RF; Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Bosinger SE; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.; Yerkes Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.; Pokaż więcej
Źródło :: BioRxiv : the preprint server for biology [bioRxiv] 2020 Sep 16. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :: Preprint

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Biomarkers of Cellular Stress Do Not Associate with sCD14 in Progressive HIV and SIV Infections in Vivo .
Autorzy :: Vinton CL; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.
Starke CE; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.
Ortiz AM; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.
Lai SH; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.
Flynn JK; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.
Sortino O; HIV Pathogenesis Section; Laboratory of Immunoregulation; NIAID, NIH; Bethesda, Maryland.
Knox K; Department of Medicine; University of Arizona; Tucson, Arizona.
Sereti I; HIV Pathogenesis Section; Laboratory of Immunoregulation; NIAID, NIH; Bethesda, Maryland.
Brenchley JM; Barrier Immunity Section; Laboratory of Viral Diseases; NIAID, NIH; Bethesda, Maryland.; Pokaż więcej
Źródło :: Pathogens & immunity [Pathog Immun] 2020 Apr 24; Vol. 5 (1), pp. 68-88. Date of Electronic Publication: 2020 Apr 24 (Print Publication: 2020).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissues.
Autorzy :: Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Ladell K; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
McLaren JE; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Lai SH; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Wu F; Nonhuman Primate Virology Section, Laboratory of Molecular Microbiology, and.
Hirsch VM; Nonhuman Primate Virology Section, Laboratory of Molecular Microbiology, and.
Darko S; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Price DA; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.; Systems Immunity Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.; Pokaż więcej
Źródło :: The Journal of clinical investigation [J Clin Invest] 2020 Feb 03; Vol. 130 (2), pp. 789-798.
Typ publikacji :: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunity, Mucosal*
CD8-Positive T-Lymphocytes/*immunology
Lymph Nodes/*immunology
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; CD8-Positive T-Lymphocytes/pathology ; Lymph Nodes/pathology ; Macaca mulatta ; Mesentery/immunology ; Mesentery/pathology ; Mucous Membrane ; Organ Specificity/immunology ; Simian Acquired Immunodeficiency Syndrome/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance.
Autorzy :: Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Magaziner SJ; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology & Microbiology, NIAID/NIH, Bethesda, Maryland, USA.
Dowd KA; Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Robertson SJ; Innate Immunity & Pathogenesis Section, Laboratory of Virology, NIAID/NIH, Hamilton, Montana, USA.
Amaro-Carambot E; Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Karmele EP; Mucosal Immunobiology Section, Laboratory of Molecular Immunology, NIAID/NIH, Bethesda, Maryland, USA.
Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Whitehead SS; Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Best SM; Innate Immunity & Pathogenesis Section, Laboratory of Virology, NIAID/NIH, Hamilton, Montana, USA.
Pierson TC; Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA.
Hickman HD; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology & Microbiology, NIAID/NIH, Bethesda, Maryland, USA.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID/NIH, Bethesda, Maryland, USA .; Pokaż więcej
Źródło :: MBio [mBio] 2019 Dec 03; Vol. 10 (6). Date of Electronic Publication: 2019 Dec 03.
Typ publikacji :: Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :: Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Acquired Immunodeficiency Syndrome/*virology
Simian Immunodeficiency Virus/*immunology
Zika Virus/*immunology
Zika Virus Infection/*immunology
Zika Virus Infection/*virology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Antiviral Agents/immunology ; Female ; Interferons/immunology ; Macaca mulatta/immunology ; Macaca mulatta/virology ; Male ; Viral Load/immunology ; Viremia/immunology ; Viremia/virology ; Virus Replication/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Simian Immunodeficiency Virus Infects Functionally Polarized Memory CD4 T Cells Equivalently In Vivo .
Autorzy :: Lai SH; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA .; Pokaż więcej
Źródło :: Journal of virology [J Virol] 2019 Apr 17; Vol. 93 (9). Date of Electronic Publication: 2019 Apr 17 (Print Publication: 2019).
Typ publikacji :: Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :: DNA, Viral/*immunology
Immunologic Memory/*drug effects
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*immunology
T-Lymphocytes, Helper-Inducer/*immunology
Animals ; Anti-Retroviral Agents/pharmacology ; Macaca mulatta ; Macaca nemestrina ; Simian Acquired Immunodeficiency Syndrome/drug therapy ; Simian Acquired Immunodeficiency Syndrome/pathology ; T-Lymphocytes, Helper-Inducer/virology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques.
Autorzy :: Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
DiNapoli SR; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Vujkovic-Cvijin I; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.
Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Lai SH; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Long ME; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Sortino O; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Johnston L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.
Busman-Sahay K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.
Belkaid Y; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.; NIAID Microbiome Program, NIH, Bethesda, MD, USA.
Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. .; Pokaż więcej
Źródło :: Nature medicine [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1313-1316. Date of Electronic Publication: 2018 Jul 30.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Disease Progression*
Dysbiosis/*microbiology
Simian Acquired Immunodeficiency Syndrome/*microbiology
Simian Acquired Immunodeficiency Syndrome/*virology
Simian Immunodeficiency Virus/*physiology
Animals ; Macaca mulatta ; Male ; Vancomycin/pharmacology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
Autorzy :: Dharmasena MN; Laboratory of Mucosal Pathogens and Cellular Immunology, Food and Drug Administration-Center for Biologics Evaluation and Research, New Hampshire Avenue, Silver Spring, Maryland, United States of America.
Feuille CM; Laboratory of Mucosal Pathogens and Cellular Immunology, Food and Drug Administration-Center for Biologics Evaluation and Research, New Hampshire Avenue, Silver Spring, Maryland, United States of America.
Starke CE; Laboratory of Mucosal Pathogens and Cellular Immunology, Food and Drug Administration-Center for Biologics Evaluation and Research, New Hampshire Avenue, Silver Spring, Maryland, United States of America.
Bhagwat AA; Environmental Microbial and Food Safety Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland, United States of America.
Stibitz S; Laboratory of Mucosal Pathogens and Cellular Immunology, Food and Drug Administration-Center for Biologics Evaluation and Research, New Hampshire Avenue, Silver Spring, Maryland, United States of America.
Kopecko DJ; Laboratory of Mucosal Pathogens and Cellular Immunology, Food and Drug Administration-Center for Biologics Evaluation and Research, New Hampshire Avenue, Silver Spring, Maryland, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2016 Sep 27; Vol. 11 (9), pp. e0163511. Date of Electronic Publication: 2016 Sep 27 (Print Publication: 2016).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Starke CE"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język